Use Able AI chat for product recommendations

Recombinant Rat gp130/IL6ST protein (hFc Tag)

种属

Rat

纯度

>90 %, SDS-PAGE

标签

hFc Tag

生物活性

未测试

Cat no : Eg0843

Print datasheet

Synonyms

gp130/IL6ST, CD130, Glycoprotein 130, gp130, IL-6 receptor subunit beta



产品信息

纯度 >90 %, SDS-PAGE
内毒素 <0.1 EU/μg protein, LAL method
生物活性
Not tested
来源 HEK293-derived Rat gp130 protein Gln23-Glu618 (Accession# NP_001008725.2) with a human IgG1 Fc tag at the C-terminus.
基因ID 25205
蛋白编号 NP_001008725.2
预测分子量 93.7 kDa
SDS-PAGE 100-130 kDa, reducing (R) conditions
组分 Lyophilized from 0.22 μm filtered solution in PBS, pH 7.4. Normally 5% trehalose and 5% mannitol are added as protectants before lyophilization.
复溶 Briefly centrifuge the tube before opening. Reconstitute at 0.1-0.5 mg/mL in sterile water.
储存条件
It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
  • Until expiry date, -20℃ to -80℃ as lyophilized proteins.
  • 3 months, -20℃ to -80℃ under sterile conditions after reconstitution.
运输条件 The product is shipped at ambient temperature. Upon receipt, store it immediately at the recommended temperature.

背景信息

Glycoprotein 130 (gp130, also known as IL6ST, CD130 or IL6-beta) is a ubiquitously expressed, signal-transducing receptor that serves as the signal transduction unit for IL-6 family of cytokines, including IL-6, IL-11, IL-27, leukemia inhibitory factor (LIF), OSM, ciliary neurotrophic factor (CNTF), cardiotrophin 1 (CT-1), and cardiotrophin-like cytokine (CLC). These cytokines signal through the gp130/Jak/STAT pathway. Binding of IL-6 to IL-6R induces gp130 homodimerization and formation of a high-affinity receptor complex, which activates Jaks. That causes phosphorylation of gp130 tyrosine residues which in turn activates STAT3. gp130 is a type I transmembrane protein, and can also exist as a soluble form (sgp130). sgp130 binds to sIL-6R/IL-6 complexes and prevents their interactions with membrane-anchored gp130 on target cells.

参考文献:

1. T Taga, et al. (1997) Review Annu Rev Immunol. 15:797-819. 2. F A Montero-Julian, et al. (1997) Clin Cancer Res. 3(8):1443-51. 3. P C Heinrich, et al. (1998) Biochem J.334 ( Pt 2)(Pt 2):297-314. 4. J S Silver, et al. (2010) Review J Leukoc Biol. 88(6):1145-56.

||
New chat

Able™

正在加载,请稍候...